BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30983072)

  • 1. Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.
    Liu P; Li X; Guo X; Chen J; Li C; Chen M; Liu L; Zhang X; Zu X
    Cell Prolif; 2019 Jul; 52(4):e12614. PubMed ID: 30983072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis.
    Li S; Liu F; Zheng K; Wang W; Qiu E; Pei Y; Wang S; Zhang J; Zhang X
    Mol Cancer; 2021 Dec; 20(1):161. PubMed ID: 34876132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA DOCK1 downregulates microRNA-124 to induce the growth of human thyroid cancer cell lines.
    Cui W; Xue J
    Biofactors; 2020 Jul; 46(4):591-599. PubMed ID: 32584497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.
    Liang H; Huang H; Li Y; Lu Y; Ye T
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32181485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0001785 inhibits the proliferation, migration and invasion of breast cancer cells in vitro and in vivo by sponging miR-942 to upregulate SOCS3.
    Li Z; Zheng J; Lin W; Weng J; Hong W; Zou J; Zhang T; Ye C; Chen Y
    Cell Cycle; 2020 Nov; 19(21):2811-2825. PubMed ID: 33054543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
    Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
    Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR‑1231 pathway in bladder cancer progression.
    Li W; Li Y; Sun Z; Zhou J; Cao Y; Ma W; Xie K; Yan X
    Int J Mol Med; 2019 Nov; 44(5):1719-1728. PubMed ID: 31545480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput sequencing identified circular RNA circUBE2K mediating RhoA associated bladder cancer phenotype via regulation of miR-516b-5p/ARHGAP5 axis.
    Yang C; Mou Z; Wu S; Ou Y; Zhang Z; Chen X; Dai X; Xu C; Mao S; Jiang H
    Cell Death Dis; 2021 Jul; 12(8):719. PubMed ID: 34285193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Zhang Z; Mou Z; Xu C; Wu S; Dai X; Chen X; Ou Y; Chen Y; Yang C; Jiang H
    Cell Death Dis; 2021 Aug; 12(8):778. PubMed ID: 34365465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223.
    Zhang X; Tan P; Zhuang Y; Du L
    Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway.
    Zeng Z; Zhou W; Duan L; Zhang J; Lu X; Jin L; Yu Y
    J Cell Physiol; 2019 Apr; 234(4):3887-3896. PubMed ID: 30146736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular forms of dedicator of cytokinesis 1 promotes breast cancer progression by derepressing never in mitosis related kinase 2 via sponging miR-128-3p.
    Ni Z; Liu W; Pan G; Mao A; Liu J; Zhang Q; Li J; Liu L; Li H
    Environ Toxicol; 2023 Jul; 38(7):1712-1722. PubMed ID: 37040338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
    Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
    Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.
    Zhong Z; Huang M; Lv M; He Y; Duan C; Zhang L; Chen J
    Cancer Lett; 2017 Sep; 403():305-317. PubMed ID: 28687357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
    Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
    Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
    Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C
    Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.